{"id":5487,"date":"2025-07-30T16:53:00","date_gmt":"2025-07-30T11:23:00","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=5487"},"modified":"2026-03-20T17:39:48","modified_gmt":"2026-03-20T12:09:48","slug":"is-parainfluenza-virus-contagious","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious","title":{"rendered":"Is Parainfluenza Virus Contagious?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69daca0c2db3c\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69daca0c2db3c\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious\/#What_is_Parainfluenza\" >What is Parainfluenza?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious\/#Parainfluenza_Viruses_Infection_Market\" >Parainfluenza Viruses Infection Market<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious\/#Parainfluenza_Virus_Infection_%E2%80%93_Unmet_Needs\" >Parainfluenza Virus Infection \u2013 Unmet Needs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>Viral infections continue to rank among the most significant public health challenges globally, disrupting everyday life, burdening healthcare systems, and contributing to considerable morbidity and mortality. Although many viral infections are self-limiting, others, such as influenza, pediatric viral pneumonia, and hepatitis, collectively lead to over 1,000 deaths each year worldwide.<\/p>\n\n\n\n<p>Respiratory viral infections are the most widespread, impacting people across all age groups. Key pathogens include influenza, respiratory syncytial virus (RSV), human parainfluenza virus (HPIV), adenovirus, and rhinovirus, all of which are major contributors to flu-like symptoms and common cold conditions.<\/p>\n\n\n\n<p>Among these, the human parainfluenza virus stands out as a critical respiratory pathogen, particularly affecting infants, young children, and immunocompromised individuals. It can infect both the upper and lower respiratory tract, making awareness of the parainfluenza virus incubation period and the parainfluenza contagious period essential for effective disease control. A common concern is is parainfluenza contagious, and the answer is yes, as it spreads efficiently through respiratory droplets and contaminated surfaces. Understanding how long is parainfluenza contagious is equally important, as transmission can occur even before symptoms fully develop and continue during the symptomatic phase. Seasonal surges are typically observed during the fall and spring, further emphasizing its public health relevance.<\/p>\n\n\n\n<p>Epidemiological data highlights the widespread burden of respiratory infections. The common cold alone accounts for 35.6 acute illnesses per 100 individuals annually, while influenza and related infections contribute to nearly one-third of physician visits in the United States. Notably, parainfluenza infections represent approximately 6.8% of pediatric healthcare visits globally, underlining their substantial clinical and economic impact.<\/p>\n\n\n\n<p>As respiratory viruses continue to evolve and re-emerge, the demand for improved diagnostics, targeted therapies, and deeper research into parainfluenza contagious dynamics, including transmission timelines and risk factors, remains critical. Strengthening our understanding of the parainfluenza virus incubation period and parainfluenza contagious period will be key to addressing unmet needs and advancing the parainfluenza virus infection market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-parainfluenza-nbsp\"><span class=\"ez-toc-section\" id=\"What_is_Parainfluenza\"><\/span>What is Parainfluenza?&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Parainfluenza refers to a group of respiratory infections caused by human parainfluenza viruses (HPIVs), which commonly affect infants, children, older adults, and immunocompromised individuals. These viruses are a leading cause of illnesses such as croup, bronchitis, and pneumonia. Many people often ask, is parainfluenza contagious, and the answer is yes. Parainfluenza is highly contagious and spreads through respiratory droplets when an infected person coughs, sneezes, or comes into close contact with others. It can also spread via contaminated surfaces, making hygiene and preventive measures crucial in limiting transmission.<\/p>\n\n\n\n<p>Understanding the parainfluenza virus incubation period is key to managing its spread. Typically, the incubation period ranges from 2 to 6 days, during which a person may not show symptoms but can still potentially spread the virus. The parainfluenza contagious period usually begins shortly before symptoms appear and continues for several days afterward. In most healthy individuals, the contagious phase lasts about 3 to 10 days; however, in young children or those with weakened immune systems, the duration can be longer. This often leads to questions like how long is parainfluenza contagious, especially in settings like schools or households where close contact is frequent.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"309\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-1024x309.png\" alt=\"types-of-HPIV\" class=\"wp-image-32966\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-1024x309.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-300x91.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-150x45.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-768x232.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-1536x464.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01170915\/There-are-4-known-types-of-HPIV-2048x619.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Because parainfluenza contagious transmission is so common, especially in crowded environments, early precautions such as handwashing, mask use, and isolating symptomatic individuals can significantly reduce spread. Recognizing the symptoms, such as cough, fever, runny nose, and in severe cases, difficulty breathing, along with awareness of the contagious timeline, helps in both early intervention and preventing outbreaks.<\/p>\n\n\n\n<p>The parainfluenza virus contagious period depends on various factors, but parainfluenza is contagious even before symptoms become evident. Transmission usually happens through direct contact with an infected person, airborne respiratory droplets, or touching contaminated surfaces and then transferring the virus to the nose or mouth. This highlights why understanding how long parainfluenza is contagious and implementing early parainfluenza treatment are crucial steps in managing its spread. For instance, parainfluenza 3, one of the more common types, is notably transmissible, making it vital to track the parainfluenza 3 contagious period, especially during seasonal peaks.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-parainfluenza-viruses-infection-market\"><span class=\"ez-toc-section\" id=\"Parainfluenza_Viruses_Infection_Market\"><\/span>Parainfluenza Viruses Infection Market<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/parainfluenza-virus-infection-market\" class=\"ek-link\">parainfluenza virus infection market<\/a><\/strong> is evolving steadily, driven by advancements in diagnosis, rising awareness, and the anticipated launch of novel therapies. According to recent estimates, there were approximately <strong>2.7 million <a href=\"https:\/\/www.delveinsight.com\/report-store\/parainfluenza-virus-infection-epidemiology-forecast\" class=\"ek-link\">incident cases of parainfluenza virus<\/a> infection in 2023 across the 7MM (US, EU4, UK, and Japan)<\/strong>. The <strong>United States<\/strong> alone accounted for over <strong>1.45 million cases<\/strong>, followed by <strong>EU4 and the UK<\/strong>, which reported more than <strong>990,000 combined cases<\/strong>. Within Europe, <strong>Spain<\/strong> recorded the highest burden, while the <strong>UK<\/strong> had the lowest reported incidence.<\/p>\n\n\n\n<p><strong>Parainfluenza<\/strong>, which is indeed <strong>contagious<\/strong>, spreads primarily via respiratory droplets and direct contact, particularly among children and immunocompromised individuals. The <strong>incubation period for parainfluenza<\/strong> typically ranges from <strong>2 to 6 days<\/strong>, and understanding <strong>how long parainfluenza is contagious<\/strong> plays a key role in infection control. Recurrent infections are common due to the absence of long-term immunity and the circulation of multiple subtypes, including <strong>parainfluenza 1, 2, 3, and 4<\/strong>. Awareness around <strong>how contagious parainfluenza is<\/strong>, especially in adults, is increasingly essential as the virus continues to impact public health systems globally.<\/p>\n\n\n\n<p>From a market standpoint, the <strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/parainfluenza-virus-infection-pipeline-insight\" class=\"ek-link\">Parainfluenza Virus Infection Drugs Market<\/a><\/strong> across the 7MM reached approximately <strong>USD 259 million in 2023<\/strong>, primarily comprising standard-of-care treatments. The <strong>US dominated the market<\/strong>, accounting for around <strong>68% of the total share<\/strong>, followed by <strong>EU4 and the UK<\/strong>, which jointly held about <strong>23%<\/strong>. <strong>Japan<\/strong>, the second-largest market after the US, is also projected to see substantial growth through 2034.<\/p>\n\n\n\n<p>Pipeline development remains a focal point, with <strong>key players like Ansun Biopharma and AlloVir<\/strong> advancing investigational therapies aimed at improving parainfluenza treatment outcomes. Their ongoing R&amp;D efforts are expected to boost the parainfluenza virus infection market size significantly in the coming years, especially as the demand grows for antiviral agents that address the recurring and often severe nature of human parainfluenza virus infections.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-parainfluenza-virus-infection-unmet-needs\"><span class=\"ez-toc-section\" id=\"Parainfluenza_Virus_Infection_%E2%80%93_Unmet_Needs\"><\/span>Parainfluenza Virus Infection \u2013 Unmet Needs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Despite the ongoing burden of illness caused by PIVs, <strong>there is currently no approved vaccine or specific antiviral treatment<\/strong> for these infections. The vast majority of cases rely on supportive care, and effective pharmaceutical interventions remain elusive. For croup associated with HPIV-1 or HPIV-2, corticosteroids have demonstrated benefit, but these are limited in scope and do not offer direct antiviral action.<\/p>\n\n\n\n<p>Promising candidates such as DAS181 are under clinical development, showing potential in treating severe infections in high-risk groups. Ribavirin is occasionally administered off-label due to its in vitro activity, but its clinical utility remains controversial due to inconsistent results and a lack of randomized controlled trial data.<\/p>\n\n\n\n<p>Additionally, live-attenuated intranasal vaccines are being explored using reverse genetics platforms for HPIV-1, -2, and -3, which may offer future prevention options in both children and adults. However, these candidates are still in the early stages of development.<\/p>\n\n\n\n<p>Beyond therapeutics, <strong>enhanced genetic surveillance and virological monitoring<\/strong> are also pressing needs. These tools would not only improve outbreak detection but also support more precise targeting of vaccine and drug development.<\/p>\n\n\n\n<p>The lack of standardized, approved therapies and the slow pace of clinical progress highlight the substantial unmet need for <strong>both prophylactic and curative<\/strong> solutions in this space.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-conclusion\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Parainfluenza virus infections represent a clear and urgent opportunity for innovation in infectious disease care. The current reliance on symptomatic management underscores a major therapeutic gap, particularly for vulnerable populations. While investigational candidates like DAS181 and novel intranasal vaccines offer hope, the road to regulatory approval and widespread access remains long.<\/p>\n\n\n\n<p>Investment in research, coupled with enhanced genomic surveillance and public health awareness, is essential to accelerate the development of effective antiviral drugs and vaccines. Bridging this unmet need would not only improve clinical outcomes but also unlock substantial commercial value in a market currently defined by limited treatment options and high clinical burden.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/parainfluenza-virus-infection-market\"><img decoding=\"async\" width=\"1024\" height=\"194\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook-1024x194.png\" alt=\"Parainfluenza Virus Infection Market Outlook\" class=\"wp-image-32967\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook-1024x194.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook-300x57.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook-150x28.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook-768x145.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook-1536x291.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/07\/01171256\/Parainfluenza-Virus-Infection-Market-Outlook.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Viral infections continue to rank among the most significant public health challenges globally, disrupting everyday life, burdening healthcare systems, and contributing to considerable morbidity and mortality. Although many viral infections are self-limiting, others, such as influenza, pediatric viral pneumonia, and hepatitis, collectively lead to over 1,000 deaths each year worldwide. Respiratory viral infections are the [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":32969,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17434,41],"tags":[5164,5166,5165],"industry":[17225],"therapeutic_areas":[17231],"class_list":["post-5487","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-facts-and-figures","category-snippets","tag-parainfluenza-virus","tag-parainfluenza-virus-epidemiology","tag-parainfluenza-virus-market","industry-pharmaceutical","therapeutic_areas-infectious-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Is Parainfluenza Virus Contagious? - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"The diagnosed Parainfluenza virus infection prevalent population in G8 countries will increase at a CAGR of 0.44%, with the largest HPIV market size...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is Parainfluenza Virus Contagious? - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"The diagnosed Parainfluenza virus infection prevalent population in G8 countries will increase at a CAGR of 0.44%, with the largest HPIV market size...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-30T11:23:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-20T12:09:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/07\/01171615\/Bispecific-Antibodies-featured-image.png\" \/>\n\t<meta property=\"og:image:width\" content=\"466\" \/>\n\t<meta property=\"og:image:height\" content=\"284\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jatin Vimal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jatin Vimal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Is Parainfluenza Virus Contagious? - DelveInsight Business Research","description":"The diagnosed Parainfluenza virus infection prevalent population in G8 countries will increase at a CAGR of 0.44%, with the largest HPIV market size...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious","og_locale":"en_US","og_type":"article","og_title":"Is Parainfluenza Virus Contagious? - DelveInsight Business Research","og_description":"The diagnosed Parainfluenza virus infection prevalent population in G8 countries will increase at a CAGR of 0.44%, with the largest HPIV market size...","og_url":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2025-07-30T11:23:00+00:00","article_modified_time":"2026-03-20T12:09:48+00:00","og_image":[{"width":466,"height":284,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/07\/01171615\/Bispecific-Antibodies-featured-image.png","type":"image\/png"}],"author":"Jatin Vimal","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Jatin Vimal","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious","url":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious","name":"Is Parainfluenza Virus Contagious? - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/07\/01171615\/Bispecific-Antibodies-featured-image.png","datePublished":"2025-07-30T11:23:00+00:00","dateModified":"2026-03-20T12:09:48+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158"},"description":"The diagnosed Parainfluenza virus infection prevalent population in G8 countries will increase at a CAGR of 0.44%, with the largest HPIV market size...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/is-parainfluenza-virus-contagious#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/07\/01171615\/Bispecific-Antibodies-featured-image.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/07\/01171615\/Bispecific-Antibodies-featured-image.png","width":466,"height":284,"caption":"Parainfluenza virus infection market"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158","name":"Jatin Vimal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","caption":"Jatin Vimal"},"sameAs":["https:\/\/www.delveinsight.com"]}]}},"author_meta":{"display_name":"Jatin Vimal","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/jatin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2025\/07\/01171615\/Bispecific-Antibodies-featured-image-300x183.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Facts and Figures<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Facts and Figures<\/span>","<span class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Parainfluenza virus<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Parainfluenza virus epidemiology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Parainfluenza virus market<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Parainfluenza virus<\/span>","<span class=\"advgb-post-tax-term\">Parainfluenza virus epidemiology<\/span>","<span class=\"advgb-post-tax-term\">Parainfluenza virus market<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 9 months ago","modified":"Updated 3 weeks ago"},"absolute_dates":{"created":"Posted on Jul 30, 2025","modified":"Updated on Mar 20, 2026"},"absolute_dates_time":{"created":"Posted on Jul 30, 2025 4:53 pm","modified":"Updated on Mar 20, 2026 5:39 pm"},"featured_img_caption":"Parainfluenza virus infection market","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/5487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=5487"}],"version-history":[{"count":5,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/5487\/revisions"}],"predecessor-version":[{"id":34788,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/5487\/revisions\/34788"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/32969"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=5487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=5487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=5487"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=5487"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=5487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}